FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306937385> ?p ?o ?g. }

• W4306937385 endingPage "28" @default.
• W4306937385 startingPage "21" @default.
• W4306937385 abstract "Abstract Disparities in care, treatment-related toxicity and health-related quality of life (HRQoL) for adolescents and young adults (AYAs, aged 15-39 years) with cancer are under-addressed partly because of limited collection of patient-reported outcomes (PROs) in cancer clinical trials (CCTs). The AYA years include key developmental milestones distinct from younger and older patients, and cancer interrupts attainment of critical life goals. Lack of consensus on a standardized approach to assess HRQoL and treatment-related toxicity in AYA CCTs has limited the ability to improve patient outcomes. The National Cancer Institute’s Clinical Trials Network AYA PRO Task Force was assembled to reach consensus on a core set of PROs and foster its integration into AYA CCTs. Eight key considerations for selecting the core PRO AYA battery components were identified: relevance to AYAs; importance of constructs across the age continuum; prioritization of validated measures; availability of measures without licensing fees; availability in multiple languages; applicability to different cancer types and treatments; ability to measure different HRQoL domains and toxicities; and minimized burden on patients and sites. The Task Force used a modified Delphi approach to identify key components of the PRO battery. The Patient-Reported Outcomes Measurement Information System (PROMIS) and the PRO Common Terminology Criteria for Adverse Events Measurement System met all criteria and were selected to assess HRQoL and treatment toxicity, respectively. Investigators are rapidly incorporating the recommendations of the Task Force into AYA trials. Inclusion of a standardized assessment of HRQoL and treatment toxicities in AYA CCTs is a vital first step to develop interventions to improve health outcomes for AYAs diagnosed with cancer." @default.
• W4306937385 created "2022-10-21" @default.
• W4306937385 creator A5000172588 @default.
• W4306937385 creator A5009818166 @default.
• W4306937385 creator A5021233041 @default.
• W4306937385 creator A5024392666 @default.
• W4306937385 creator A5033277609 @default.
• W4306937385 creator A5033691464 @default.
• W4306937385 creator A5035514847 @default.
• W4306937385 creator A5036058743 @default.
• W4306937385 creator A5037443640 @default.
• W4306937385 creator A5039180386 @default.
• W4306937385 creator A5041894015 @default.
• W4306937385 creator A5044457816 @default.
• W4306937385 creator A5050639550 @default.
• W4306937385 creator A5056341385 @default.
• W4306937385 creator A5057696542 @default.
• W4306937385 creator A5063192858 @default.
• W4306937385 creator A5080184636 @default.
• W4306937385 creator A5082597717 @default.
• W4306937385 creator A5089586569 @default.
• W4306937385 date "2022-10-21" @default.
• W4306937385 modified "2023-10-17" @default.
• W4306937385 title "Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials" @default.
• W4306937385 cites W1655534105 @default.
• W4306937385 cites W1788933934 @default.
• W4306937385 cites W1842042263 @default.
• W4306937385 cites W1858508207 @default.
• W4306937385 cites W1966751670 @default.
• W4306937385 cites W1971996215 @default.
• W4306937385 cites W1976304582 @default.
• W4306937385 cites W1982946927 @default.
• W4306937385 cites W1985564128 @default.
• W4306937385 cites W2007010480 @default.
• W4306937385 cites W2023792923 @default.
• W4306937385 cites W2025429949 @default.
• W4306937385 cites W2043517828 @default.
• W4306937385 cites W2053601856 @default.
• W4306937385 cites W2062284639 @default.
• W4306937385 cites W2113464761 @default.
• W4306937385 cites W2126285244 @default.
• W4306937385 cites W2130986983 @default.
• W4306937385 cites W2142818804 @default.
• W4306937385 cites W2149564130 @default.
• W4306937385 cites W2152045194 @default.
• W4306937385 cites W2159516675 @default.
• W4306937385 cites W2165712213 @default.
• W4306937385 cites W2177687652 @default.
• W4306937385 cites W2256194856 @default.
• W4306937385 cites W2257617433 @default.
• W4306937385 cites W2413118791 @default.
• W4306937385 cites W2549485933 @default.
• W4306937385 cites W2592227277 @default.
• W4306937385 cites W2606404491 @default.
• W4306937385 cites W2761265752 @default.
• W4306937385 cites W2803777775 @default.
• W4306937385 cites W2897416913 @default.
• W4306937385 cites W2902212686 @default.
• W4306937385 cites W2905365274 @default.
• W4306937385 cites W2912349317 @default.
• W4306937385 cites W2914585936 @default.
• W4306937385 cites W2945481435 @default.
• W4306937385 cites W2995874200 @default.
• W4306937385 cites W2997056541 @default.
• W4306937385 cites W3003917950 @default.
• W4306937385 cites W3016559717 @default.
• W4306937385 cites W3036884707 @default.
• W4306937385 cites W3084627750 @default.
• W4306937385 cites W3086473620 @default.
• W4306937385 cites W3093002449 @default.
• W4306937385 cites W3093444544 @default.
• W4306937385 cites W3095896260 @default.
• W4306937385 cites W3111168380 @default.
• W4306937385 cites W3159764059 @default.
• W4306937385 cites W3188903013 @default.
• W4306937385 cites W4200222294 @default.
• W4306937385 cites W4200333226 @default.
• W4306937385 cites W4221033594 @default.
• W4306937385 doi "https://doi.org/10.1093/jnci/djac166" @default.
• W4306937385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36266760" @default.
• W4306937385 hasPublicationYear "2022" @default.
• W4306937385 type Work @default.
• W4306937385 citedByCount "10" @default.
• W4306937385 countsByYear W43069373852023 @default.
• W4306937385 crossrefType "journal-article" @default.
• W4306937385 hasAuthorship W4306937385A5000172588 @default.
• W4306937385 hasAuthorship W4306937385A5009818166 @default.
• W4306937385 hasAuthorship W4306937385A5021233041 @default.
• W4306937385 hasAuthorship W4306937385A5024392666 @default.
• W4306937385 hasAuthorship W4306937385A5033277609 @default.
• W4306937385 hasAuthorship W4306937385A5033691464 @default.
• W4306937385 hasAuthorship W4306937385A5035514847 @default.
• W4306937385 hasAuthorship W4306937385A5036058743 @default.
• W4306937385 hasAuthorship W4306937385A5037443640 @default.
• W4306937385 hasAuthorship W4306937385A5039180386 @default.
• W4306937385 hasAuthorship W4306937385A5041894015 @default.
• W4306937385 hasAuthorship W4306937385A5044457816 @default.
• W4306937385 hasAuthorship W4306937385A5050639550 @default.

• next